Evidence map›Paper›PMID 39485610›Full record

ArticleReproductive sciences (Thousand Oaks, Calif.)2024

Novel Loss-of-function Variants of ZP3 Associated with Premature Ovarian Insufficiency.

Lang Zhou, Xi Yang, Shuting Ren, Yuncheng Pan, Zixue Zhou, Yiqing Liu, Jitong Mo, Feng Zhang, Xiaojin Zhang, Yanhua Wu

Abstract read
PubMed Publisher
In one paragraph

Article in Reproductive sciences (Thousand Oaks, Calif.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lang Zhou *School of Life Sciences, Human Phenome Institute, Fudan University, Shanghai, 200433, China.
Xi Yang *School of Life Sciences, Human Phenome Institute, Fudan University, Shanghai, 200433, China.
Shuting RenSchool of Life Sciences, Human Phenome Institute, Fudan University, Shanghai, 200433, China.
Yuncheng PanSchool of Life Sciences, Human Phenome Institute, Fudan University, Shanghai, 200433, China.
Zixue ZhouSchool of Life Sciences, Human Phenome Institute, Fudan University, Shanghai, 200433, China.
Yiqing LiuSchool of Life Sciences, Human Phenome Institute, Fudan University, Shanghai, 200433, China.
Jitong MoSchool of Life Sciences, Human Phenome Institute, Fudan University, Shanghai, 200433, China.
Feng ZhangSchool of Life Sciences, Human Phenome Institute, Fudan University, Shanghai, 200433, China.
Xiaojin ZhangObstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai, 200011, China. zxjgcp@sina.com.
Yanhua WuSchool of Life Sciences, Human Phenome Institute, Fudan University, Shanghai, 200433, China. yanhuawu@fudan.edu.cn.ORCID 0000-0002-2803-809X

Funding

National Key R&D Program of China 2022YFC2703800National Natural Science Foundation of China 32270658
6 · The paper itself

Abstract

Premature ovarian insufficiency (POI) is one of the leading causes of female infertility. To date, the genetic etiology of POI has been elucidated in approximately 20-25% of the total cases. The human zona pellucida (ZP) plays an important role in the organization and differentiation of granulosa cells, follicle formation, and sperm recognition. Mutations in ZP1, ZP2, and ZP3 have been reported to cause female infertility due to oocyte degeneration, empty follicle, or in vitro fertilization failure. In this study, we identified three novel missense mutations in ZP3 (NM_001110354.2): c.643G > A (p.Asp215Asn), c.215 C > T (p.Thr72Ile), and c.152T > C (p.Leu51Pro) in three sporadic Han Chinese POI patients through whole-exome sequencing. These variants are absent from population databases and were predicted to be deleterious by multiple in silico tools. Structure prediction analysis showed that the affected amino acid altered the ZP3 protein structure. Western blot further confirmed that these ZP3 variants reduced the expression and secretion of ZP components. In summary, this study reports three novel deleterious variants in ZP3 associated with POI, thereby broadening the mutation spectrum of ZP3 in POI patients.

Indexed as

Loss of Function MutationMutation, MissensePrimary Ovarian InsufficiencyZona Pellucida GlycoproteinsAdultEast Asian PeopleExome SequencingFemaleGenetic Predisposition to DiseaseHumansZona Pellucida GlycoproteinsZP3 protein, humanMissense mutationPremature ovarian insufficiency (POI)Protein expressionWhole-exome sequencing (WES)ZP3

Identifiers

PMID39485610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.